Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

by Rashikh Choudhury, Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, Daniel S. Talmor, Trevor L. Nydam, Michael B. Yaffe
Published 2020-04-01

Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID‐19: Study design of the phase IIa STARS trial

by Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhunwala, Robert C. McIntyre, Peter K Moore, Janice Wang, Negin Hajizadeh, Daniel S. Talmor, Angela Sauaia, Michael B. Yaffe
Published 2020-08-01

Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review

by Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, John Burke, Fei Hua, Joshua Apgar, Daniel S. Talmor, Angela Sauaia, Deborah R. Liptzin, Livia A. Veress, Michael B. Yaffe
Published 2020-05-01